MENU
BHVN
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Biohaven (BHVN) Ownership - Who owns Biohaven?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.67B
P/E Ratio
N/A
Total Cash
378.82M
Projected Growth
N/A
Total Debt
28.99M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.75
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BHVN
Capitalization
3.67B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
379M
Total Cash/Share
3.75
Total Debt
29M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
316M
P/B Ratio
11.60
Cash Flow
N/A
Earnings
-9.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.38B
Current Ratio
2.89
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-841.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-180.09
Shares Held By Institutions
5.12B
Shares Outstanding - Current
101M
Total Liabilities
195M
Total Volume MTD
N/A
Value
-1
Gain YTD
-15.280
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com